CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 89 enrolled
Drug / intervention
Enbreldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01188655
NCT01188655N/ACompleted
CompareCT.gov

Observational Non-Interventional Study With Enbrel in Patients With Ankylosing Spondylitis

Pfizer·observational·Posted Aug 25, 2010·Updated Sep 12, 2011

In Brief

An observational study evaluating Enbrel for Spondylitis, Ankylosing. Completed, enrolled 89 participants.

Detailed Summary

This observational study will be a documentation of the prescribing and administration practices of Enbrel® and their impact on ankylosing spondylitis patients outcome in a real life setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSpondylitis, Ankylosing
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 25, 2010
Enrollment StartMay 1, 2008
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 15.9 years ago

Interventions

Enbreldrug

The patients will be treated in accordance with the requirements of the labeling of Enbrel® in Austria. The dosage and duration of therapy is to be determined by the physician to meet the patients' individual needs for treatment. To record complete dosing information, initial dose will be documented at baseline and any change will be documented with date, dose and reason at the subsequent visits.